Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer
Main Authors: | Margaret Ndinguri, Lisa Middleton, Jason Unrine, Shu Lui, Joseph Rollins, Emma Nienaber, Cassidy Spease, Aggie Williams, Lindsay Cormier |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10564129/?tool=EBI |
Similar Items
-
Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer.
by: Margaret Ndinguri, et al.
Published: (2023-01-01) -
Synthesis of Radiolabeled Technetium- and Rhenium-Luteinizing Hormone-Releasing Hormone (99mTc/Re-Acdien-LHRH) Conjugates for Targeted Detection of Breast Cancer Cells Overexpressing the LHRH Receptor
by: Lindsay E. Calderon, et al.
Published: (2021-01-01) -
The role of nitric oxide in the hypothalamic control of LHRH and oxytocin release, sexual behavior and aging of the LHRH and oxytocin neurons.
by: Jarosław Całka
Published: (2006-04-01) -
Interaction between NO and oxytocin: Influence on LHRH release
by: V. Rettori, et al.
Published: (1997-04-01) -
Expression of Luteinizing Hormone-Releasing Hormone (LHRH) and Type-I LHRH Receptor in Transitional Cell Carcinoma Type of Human Bladder Cancer
by: Zsuzsanna Szabó, et al.
Published: (2021-02-01)